(Q40896363)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

C J van Moorsel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A M Bergman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G Veerman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D A Voorn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

V W Ruiz van Haperen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H M Pinedo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G J Peters

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

1474

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

5-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Postconfluent multilayered cell line cultures for selective screening of gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

In vitro and in vivo studies on the combination of Brequinar sodium (DUP-785; NSC 368390) with 5-fluorouracil; effects of uridine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Induction of in vivo resistance against gemcitabine (dFdC, 2',2'-difluoro-deoxycytidine).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Increased sensitivity to gemcitabine of P-gP and MRP overexpressing human non-small cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Physiological concentrations of purines and pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Enhancement of anti-neoplastic activity of cytosine arabinoside against human HL-60 myeloid leukemic cells by 3-deazauridine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effects

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2899%2900209-3

7 January 2021

10.1016/S0304-4165(99)00209-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699484%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference